NCT07007325Not yet recruitingPhase 1
Prospective feasibility pilot study evaluating the value of [68Ga]Ga-PENTIXAFOR PET-CT in patients with locally advanced or metastatic Small Cell Lung Cancer (SCLC) at diagnosis and disease progression (PASSIFLORE)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 12 Mar 2026
- Status (registry)
- Not yet recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 31 Jan 2025
- Start date
- 29 Jan 2026
- Lead sponsor
- Institut De Cancerologie De L Ouest
- Diseases
- Lung cancer
- NCT number
- NCT07007325
- EU CT number
- 2024-514057-30-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 15
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut de Cancerologie de L'Ouest Coordinator of this site? Confirm its status | Angers | France | Not yet recruiting |
| Centre Hospitalier Regional D'Angers Coordinator of this site? Confirm its status | Angers | France | Not yet recruiting |
| Institut De Cancerologie De L Ouest Coordinator of this site? Confirm its status | Saint-Herblain Cedex | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.